Lower extremity revascularization (LER), a surgical procedure that can restore blood flow to blocked arteries in the legs, is often necessary for people with peripheral artery disease (PAD). While it ...

Adding the oral anticoagulant rivaroxaban (Xarelto, Janssen) to standard therapy after myocardial infarction (MI) or unstable angina significantly reduced the risk for cardiovascular mortality, data ...

Patients with PAD who meet criteria for frailty can reap similar benefits as their nonfrail counterparts when prescribed a combination of low-dose direct oral anticoagulant and aspirin following lower ...

) today announced additional results of a Phase 2 proof-of-concept study that showed andexanet alfa's ability to immediately reverse the anticoagulation activity of XARELTO^® (rivaroxaban) through the ...

Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a nationwide cohort study.